Talk to Alexandra

(866) 682 9815

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, June 2013

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

1-50 of about 7 300 reports
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

  • Industries : Drug and Medication
Vaccines - European Markets Package

Vaccines - European Markets Package

  • $ 11 691
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : Europe
Vaccines - Asian Markets Package

Vaccines - Asian Markets Package

  • $ 10 494
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Asian countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : Asia
Vaccines - Eastern European Markets Package

Vaccines - Eastern European Markets Package

  • $ 7 701
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Eastern European countries. The studies provide essential market ...

  • Industries : Drug and Medication
  • Countries : Europe
Global Markets for Orphan Drugs

Global Markets for Orphan Drugs

  • $ 5 450
  • Industry report
  • June 2013
  • by BCC Research

INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview ...

  • Industries : Drug and Medication
  • Countries : World
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Brazil
PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : China
PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - United States Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : United States
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Germany
PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Italy
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Spain
PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Japan
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory ...

  • Industries : Drug and Medication
  • Countries : United States
Vaccines - Top 10 Global Markets Package

Vaccines - Top 10 Global Markets Package

  • $ 5 174
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : World, United States, United Kingdom, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Vaccines - American Markets Package

Vaccines - American Markets Package

  • $ 5 174
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different American countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : United States
Global Markets for Orphan Drugs - Focus on Non-Biologics

Global Markets for Orphan Drugs - Focus on Non-Biologics

  • $ 4 400
  • Industry report
  • June 2013
  • by BCC Research

INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview ...

  • Industries : Drug and Medication
  • Countries : World
Global Markets for Orphan Drugs - Focus on Biologics

Global Markets for Orphan Drugs - Focus on Biologics

  • $ 4 400
  • Industry report
  • June 2013
  • by BCC Research

INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview ...

  • Industries : Drug and Medication
  • Countries : World
 Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

  • $ 4 395
  • Industry report
  • November 2013
  • by Transparency Market Research

This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...

  • Industries : Drug and Medication
  • Countries : World
Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines

Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines

Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Apoptosis and Peptides

Triple Analysis: Melanoma, Apoptosis and Peptides

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Angiogenesis and Peptides

Triple Analysis: Melanoma, Angiogenesis and Peptides

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Apoptosis and Cancer Vaccines

Triple Analysis: Melanoma, Apoptosis and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines

Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Cancer Vaccines and Peptides

Triple Analysis: Melanoma, Cancer Vaccines and Peptides

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Protein Kinase Inhibitors and Peptides

Triple Analysis: Melanoma, Protein Kinase Inhibitors and Peptides

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area ...

  • Industries : Drug and Medication
Triple Analysis: Melanoma, Pancreatic Cancer and Cancer Vaccines

Triple Analysis: Melanoma, Pancreatic Cancer and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is ...

  • Industries : Drug and Medication

» Read our Company Profiles

84 Companies

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.